This book is a comprehensive reference that explores the latest innovations in vaccine delivery technologies, focusing on how novel platforms such as nanoparticles, liposomes, microneedles, and smart polymers are revolutionizing immunization strategies. It bridges fundamental research with clinical applications, examining how advanced delivery systems improve vaccine efficacy, stability, targeted delivery, and patient compliance. It addresses key challenges in formulation, manufacturing, and regulatory approval, while highlighting successful case studies, including mRNA and cancer vaccines, as well as emerging trends in personalized immunization and next-generation delivery approaches. By fostering a deeper understanding of advanced drug delivery systems, this book supports innovation and informed decision-making in the rapidly evolving landscape of vaccine development and deployment. This book is intended for researchers, industry professionals, and regulatory experts in pharmaceutical sciences, biotechnology, and immunology.

Vivek P. Chavda is an Assistant Professor in the Department of Pharmaceutics and Pharmaceutical Technology at L. M. College of Pharmacy, Ahmedabad, Gujarat, India. He is a B.Pharm. and M.Pharm. gold medalist from Gujarat Technological University. Before joining academia, he worked in the biologics industry for almost eight years, conducting research and development in biologics at Lupin Biotech, Pune, and Dr. Reddy’s Laboratories, Hyderabad.

He has more than 300 national and international publications, 50 book chapters, 10 additional book chapters under communication, 20 edited reference books, seven patents in the pipeline, and numerous newsletter articles to his credit. He has an H-index of 53 and was listed among the world’s top 2% of scientists by Stanford University and Elsevier in 2023, 2024, and 2025.

He also serves as an editorial board member for various Scopus-indexed journals, including Military Medical Research (Impact Factor 19), Oncology Research (Impact Factor 4.9), Frontiers in Medicine (Impact Factor 3.7), iMetaMed (Wiley), Clinical Complementary Medicine and Pharmacology (Elsevier), and Outbreak Management and Response (Taylor & Francis). He is also a guest editor for MDPI, Frontiers, and Springer Nature. He is an active reviewer for Scopus-indexed journals, with impact factors ranging from 2 to 73.

His research interests include the development of biologics processes and formulations, medical device development, complex injectables, nanodiagnostics and non-carrier formulations, long-acting parenteral formulations, and nanovaccines.